Despite many effective treatments for gout, its management remains a challenge internationally. Options for optimizing gout management may differ in different practice sizes and settings. Gout incidence is rising and it continues to be associated with increased mortality. Education of patients and medical providers is essential, and newer gout medications need to be used in the most appropriate ways for cost-effective therapy. Special consideration needs to be given to such populations as the elderly and those with renal and cardiovascular disease in gout management. New agents are in development, which may add to the armamentarium for gout management.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.rdc.2018.09.009 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!